1273443

Aucta Pharmaceuticals, Inc. — FEI 3029416323

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 9, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Basking Ridge, NJ (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)